Article
p53 functional assays: detecting p53 mutations in both the germline and in sporadic tumours.
Cell proliferation - 1 Feb 2001
Camplejohn R S, Rutherford J
Abstract excerpt
The tumour suppressor gene p53 is the gene most often reported to be mutated in clinical cancers with something like half of all tumours harbouring mutations. Further, many studies have suggested that p53 mutations have prognostic importance and sometimes are a significant factor in determining the response of tumours to therapy. The value of knowing the p53 status of individual tumours will increase if currently...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
